Gross Tumor and Intracranial Control Benefits with Fractionated Radiotherapy Compared with Stereotactic Radiosurgery for Patients with WHO Grade 2 Meningioma
-
Published:2024-08
Issue:
Volume:188
Page:e259-e266
-
ISSN:1878-8750
-
Container-title:World Neurosurgery
-
language:en
-
Short-container-title:World Neurosurgery
Author:
Gravbrot NicholasORCID,
Rock Calvin B.ORCID,
Weil Christopher R.,
Rock Christian B.,
Burt Lindsay M.,
DeCesaris Cristina M.,
Jensen Randy L.ORCID,
Shrieve Dennis C.,
Cannon Donald M.
Reference44 articles.
1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015-2019;Ostrom;Neuro Oncol,2022
2. Meningioma: a review of epidemiology, pathology, diagnosis, treatment, and future directions;Ogasawara;Biomedicines,2021
3. Low-risk meningioma: initial outcomes from NRG oncology/RTOG 0539;Rogers;Neuro Oncol,2023
4. Radiation therapy for WHO grade I meningioma;Day;Chin Clin Oncol,2017
5. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review;Rogers;J Neurosurg,2015